Company / Current Assets
AVADEL PHARMACEUTICALS PLC Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$134.2M
FY2024
5-year range
$100.8M / $263.5M
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
#198 of 213
Health Care
What the data says
Among 213 Health Care companies, AVADEL PHARMACEUTICALS PLC is in the bottom 7% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $82M in FY2019 to $263M in FY2020.
Based on SEC 10-K filings.
$134M in FY2024 with a 5-year CAGR of +10.3%.
Improved from $101M to $134M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 213This company $134.2M Sector average $2.5B
▼
-94.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.3%, indicating consistent growth.
- In FY2024, current assets increased 0.0% year-over-year.
- Ranks #198 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $134.2M | +0.0% |
| FY2023 | $134.2M | +33.1% |
| FY2022 | $100.8M | -47.6% |
| FY2021 | $192.5M | -26.9% |
| FY2020 | $263.5M | +219.8% |
| FY2019 | $82.4M | -34.0% |
| FY2018 | $124.9M | +0.7% |
| FY2017 | $124.0M | -31.6% |
| FY2016 | $181.2M | +8.9% |
| FY2015 | $166.4M | +48.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026